No Data
Emerging Markets Stock Digest: Synbio Pharmaceuticals continues to fall, Business Coach temporarily hits the upper limit.
＜4263＞ Susmed 582 +7 rebound. It was announced that the operation of a clinical trial system (SUSMED SDS) utilizing Blockchain Technology was started in a doctor-led clinical trial at the National Center of Neurology and Psychiatry. This clinical trial targets patients with myalgic encephalomyelitis/chronic fatigue syndrome, aiming to verify the efficacy and safety of Rituximab. Utilizing SUSMED SDS, it aims to reduce monitoring tasks and improve the quality and reliability of the data obtained.
Hot Stocks Digest (Morning Session): Sekisui Chemical, J. Front, Towns, ETC.
Sekisui Chemical Co. (<4204>): 2,647.5 yen (+193.5 yen) showing significant continued growth. It has been reported that the company will invest approximately 310 billion yen in the mass production of the next-generation Solar Cells "Perovskite Type" and is planning to construct a new factory in Sakai City. Operations are scheduled to commence by 2030, and the production capacity is expected to be around 1 million kW in power generation capacity for the batteries. This seems equivalent to the power generation capacity of one Nuclear Power plant. The government is likely to subsidize about 160 billion yen, which is half of the investment. Expectations for future market expansion are high.
Ortz --- rebounding, acquiring stocks of Wasabi and Green & Digital Partners and becoming a subsidiary.
The company announced the acquisition of wasabi and Green & Digital Partners stocks to establish subsidiaries. Wasabi's strengths can enhance business development and system development capabilities in the company's AI Solutions business, which is determined to contribute to the improvement of corporate value within the group. Green & Digital Partners aims to separate its SES and DX consulting business, led by wasabi's representative director, Takuji Kuriyama.
Strong performance, support for stock prices could be attributed to buying for Dividends, ETC.
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to show a strong performance. The US stock market was closed yesterday, December 25th, due to the Christmas holiday. The major European markets were also closed, leaving few clues, while in the foreign exchange market, the dollar remains at 157.40 yen, continuing to indicate a trend of yen depreciation and dollar strength, providing reassurance in the Tokyo market. Additionally, today is the final trading day for the rights to receive dividends for companies with December fiscal year-end, and buying for dividends and shareholder benefits is expected to support stock prices. Meanwhile, overseas investment
Station exploration, WealthNavi and others [Emerging Markets press release]
Acquisition of shares in Wasabi and Green & Digital Partners engaged in the Orts SES business and subsidiary establishment. Basic agreement on business collaboration with Four Seasons HD, which is involved in the Jelly Beans mail order business. Large-scale exercise of the 29th subscription rights of Accel M (with exercise price adjustment clause), the number of shares to be delivered from the 3rd is 1.06 million 4600 shares. Business partnership contract signed with Ekitan Regional Newspaper Company.
Stocks that moved the day before part 2: Osaka Oil Chemical Industry, Ubiquitous AI, Stem Cell Research Institute ETC.
Stock Name <Code> Closing Price on the 18th ⇒ Change from the Previous Day Toyo Securities <8614> 561 -46 Announced Share Buyback in Off-Hours Trading but feelings of exhaustion prevail. Unichika <3103> 143 -7 Continuation of negative views on stock value dilution. SOFTBANK GROUP CO <9984> 9434 -403 Following major investments in the USA, there was a significant rise on the 17th. Canon Inc-Spons Adr <7739> 2464 -48 The small rocket of Space One had a launch failure. Sumitomo Pharma <4506>
No Data